Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model

A novel glycylcycline agent, tigecycline (GAR-936), was evaluated in vivo in the mouse model of peritonitis against three Enterococcus faecalis and four Enterococcus faecium isolates with different susceptibilities to vancomycin and tetracyclines, all of which were inhibited by ≤0.125 μg of tigecycl...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Nannini, Esteban C., Pai, Suresh R., Singh, Kavindra V., Murray, Barbara E.
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2003
Schlagworte:	Experimental Therapeutics
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151755/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543654/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.529-532.2003
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!